Preliminary discovery of quality marker of herb Meconopsis integrifolia (non flower parts) based on spectrum-effect relationship
10.7501/j.issn.0253-2670.2020.17.021
- VernacularTitle: 基于谱效关系的藏药材全缘叶绿绒蒿全草非花入药部位抗氧化质量标 志物初步研究
- Author:
Yan-Fei HUANG
1
Author Information
1. Ethnic Medicine Institute, Southwest Minzu University
- Publication Type:Journal Article
- Keywords:
Flavonoids;
Herb Meconopsis integrifolia (Maxim.) Franch (Non flower parts);
Quality marker;
Spectrum-effect relationship;
UPLC
- From:
Chinese Traditional and Herbal Drugs
2020;51(17):4521-4530
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To establish a study method for discovering quality marker of herb Meconopsis integrifolia (Non flower parts) based on spectrum-effect relationship for its quality control. Methods: UPLC fingerprints and UPLC-ESI-Q-TOF-MS/MS method were used to identify the chemical components of 10 batches of HMI extracts. The total antioxidant capacity, ABTS free radical scavenging ability, DPPH free radical scavenging ability and superoxide anion free radical suppression ability of 10 batches of sample were determined. Principal component analysis was used to screen antioxidant capacity index for HMI. Grey relational analysis was used to analyze the correlation between antioxidant capacity index and common peak of fingerprint spectrum. Then, quality marker could be preliminarily discovered by comprehensive analysis associated with antioxidant capacity index and efficacy-related constituents. Finally, the constituents were separated by HSCCC. Results: A total of 29 common peaks were identified from fingerprints of HMI extracts. 18 constituents were identified by UPLC-ESI-Q-TOF-MS/MS analysis, including 16 flavonoids and two alkaloids. DPPH scavenging ability was screened by principal component analysis which could reflect the antioxidant capacity of HMI extracts. Grey relational analysis showed that the correlations between the 29 common peaks and DPPH scavenging ability were all greater than 0.5. The quality markers of HMI were quercetin 3-O-β-D-glucopyrannosy-(1→6)-β-D-glucopyranoside and quercetin 3-O-[2'''-O-acetyl-β-D-galactopyranosyl-(1→6)-β-D-glucopyranoside] by comprehensive analysis. Among them, quercetin 3-O-[2'''-O-acetyl-β-D-galactopyranosyl-(1→6)-β-D- glucopyranoside] is a new compound. Conclusion: Study on the quality marker of HMI based on the spectrum-effect relationship is of great significance for elucidating the pharmacodynamic material basis, screening core quality marker related to medicinal effect, and ensuring the safety and rational application of traditional medicines.
